Ahern, T.P. et al. 2016. Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study. Acta Oncologica. 55, 6 (Jun. 2016), 734–741. DOI:https://doi.org/10.3109/0284186X.2016.1150606.